COST-EFFECTIVENESS OF CANNABIDIOL (CBD) FOR THE TREATMENT OF SEIZURES IN PATIENTS WITH TREATMENT-RESISTANT LENNOX-GASTAUT SYNDROME OR DRAVET SYNDROME IN THE NETHERLANDS

被引：0
|
作者：
Siddiqui, J. [1 ]
Bowditch, S. [2 ]
机构：
[1] FIECON Ltd, London, England
[2] Jazz Pharmaceut, London, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE400
引用
收藏
页码：S127 / S128
页数：2
相关论文
共 50 条
  • [1] Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome
    Lattanzi, S.
    Trinka, E.
    Russo, E.
    Striano, P.
    Citraro, R.
    Silvestrini, M.
    Brigo, F.
    DRUGS OF TODAY, 2019, 55 (03) : 177 - 196
  • [2] Cost-Utility Analysis of Add-on Cannabidiol vs Usual Care Alone for the Treatment of Seizures in Patients With Treatment-Resistant Lennox-Gastaut Syndrome or Dravet Syndrome in the Netherlands
    Siddiqui, Jamshaed
    Bowditch, Sally
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2024, 11 (02): : 168 - 179
  • [3] Cannabidiol for Treatment of Patients With Seizures Associated With Lennox-Gastaut Syndrome
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (04) : 546 - 546
  • [4] Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome
    Edward E. Neuberger
    Josh J. Carlson
    David L. Veenstra
    PharmacoEconomics, 2020, 38 : 1237 - 1245
  • [5] Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome
    Neuberger, Edward E.
    Carlson, Josh J.
    Veenstra, David L.
    PHARMACOECONOMICS, 2020, 38 (11) : 1237 - 1245
  • [6] The Curious Case of Lennox-Gastaut Syndrome: Treatment-Resistant Seizures in a Patient With Autism Spectrum Disease With Lennox-Gastaut Syndrome
    Anvekar, Priyanka
    Lohana, Petras
    Elmahal, Mohammed
    Ali, Syed R.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [7] Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
    Kelly Hollenack
    Jade Marshall
    PharmacoEconomics, 2021, 39 : 473 - 475
  • [8] Comment on "Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome"
    Hollenack, Kelly
    Marshall, Jade
    PHARMACOECONOMICS, 2021, 39 (04) : 473 - 475
  • [9] Fenfluramine for the Treatment of Dravet Syndrome and Lennox-Gastaut Syndrome
    Balagura, Ganna
    Cacciatore, Marta
    Grasso, Eleonora A.
    Striano, Pasquale
    Verrotti, Alberto
    CNS DRUGS, 2020, 34 (10) : 1001 - 1007
  • [10] Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea
    Koo, Chung Mo
    Kim, Se Hee
    Lee, Joon Soo
    Park, Byung Joo
    Lee, Hae Kook
    Kim, Heung Dong
    Kang, Hoon Chul
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (50)
12345